How to set up a psychodermatology clinic

Aguilar-Duran, S.; Ahmed, Alia; Taylor, R.; Bewley, Anthony

doi:10.1111/ced.12360

Cited by 24 publications

(42 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…We found a significantly higher prevalence of clinical depression (10.1% vs. 4.3%), anxiety disorder (17.2% vs. 11.1%), and suicidal ideation (12.7% vs. 8.3%) among patients with common skin diseases compared with controls. These findings, from a wide geographical, cultural, and socio-economic base, have relevance for clinical services across Europe ( Aguilar-Duran et al , 2014 ) because of the high prevalence of skin diseases.…”

Section: Discussionmentioning

confidence: 78%

The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries

Dalgard

Gieler

Tómas-Aragonés

et al. 2015

Journal of Investigative Dermatology

690

703

View full text Add to dashboard Cite

The contribution of psychological disorders to the burden of skin disease has been poorly explored, and this is a large-scale study to ascertain the association between depression, anxiety, and suicidal ideation with various dermatological diagnoses. This international multicenter observational cross-sectional study was conducted in 13 European countries. In each dermatology clinic, 250 consecutive adult out-patients were recruited to complete a questionnaire, reporting socio-demographic information, negative life events, and suicidal ideation; depression and anxiety were assessed with the Hospital Anxiety and Depression Scale. A clinical examination was performed. A control group was recruited among hospital employees. There were 4,994 participants––3,635 patients and 1,359 controls. Clinical depression was present in 10.1% patients (controls 4.3%, odds ratio (OR) 2.40 (1.67–3.47)). Clinical anxiety was present in 17.2% (controls 11.1%, OR 2.18 (1.68–2.82)). Suicidal ideation was reported by 12.7% of all patients (controls 8.3%, OR 1.94 (1.33–2.82)). For individual diagnoses, only patients with psoriasis had significant association with suicidal ideation. The association with depression and anxiety was highest for patients with psoriasis, atopic dermatitis, hand eczema, and leg ulcers. These results identify a major additional burden of skin disease and have important clinical implications.

show abstract

Section: Discussionmentioning

confidence: 78%

The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries

Dalgard

Gieler

Tómas-Aragonés

et al. 2015

Journal of Investigative Dermatology

690

703

View full text Add to dashboard Cite

show abstract

“…Moreover, large-scale studies have evaluated the association between depression, anxiety and suicidal ideation with psoriasis. A significantly higher prevalence of psychological and psychiatric disorders in patients suffering from psoriasis has been reported (6)(7)(8).…”

mentioning

confidence: 99%

Patients with Moderate to Severe Psoriasis Associate with Higher Risk of Depression and Anxiety Symptoms: Results of a Multivariate Study of 300 Spanish Individuals with Psoriasis

Tribó¹,

Turroja²,

Castaño‐Vinyals³

et al. 2019

Acta Derm Venerol

View full text Add to dashboard Cite

Population-based studies indicate that psoriasis associates a greater risk of comorbidities that alter mood, such as anxiety and, above all, depression. We applied a complete panel of validated questionnaires to perform a full psychopathological exploration according to the DSM-V classification of psychiatric diseases in 300 psoriatic patients. A dose-response association with depression and anxiety (the more severe psoriatic patients have more risk of having depression or anxiety) was observed. The Montgomery-Asberg Depression Rating, Hamilton Rating for Depression, Hospital Anxiety and Depression scales (for depression), and State Anxiety Inventory (for anxiety) seem to better detect such mood comorbidities in psoriatic patients. Psoriasis is a chronic skin disease associated with considerable physical and psychological comorbidities. Stress and emotional disturbances have been implicated in both triggering the onset and exacerbation of psoriasis. In order to determine the level of perceived stress and mood alterations in patients with psoriasis and their association with disease severity, 300 individuals completed diverse validated questionnaires assessing stress and psychological mood. Evaluation of perception of disease was also measured. A significant association between psoriasis severity and mood, emotional disturbances and an impact on assessments of the quality of life were observed. Particularly, Montgomery-Asberg Depression Rating Scale, Hamilton Rating Scale and Hospital Anxiety and Depression Scale for Depression detected a significant risk for depression in relation to the disease severity. The association between depression features, anxiety and perceived stress with psoriasis severity is important and can influence the appropriate management of psoriasis.

show abstract

“…National Institute for Health and Clinical Excellence guidelines recommend cognitive behavioural therapy that is specific for body dysmorphic disorder, which follows a protocol over [16][17][18][19][20][21][22][23][24] sessions. 17 Evidence for cognitive behavioural therapy is based on four randomised controlled trials of cognitive behavioural therapy v waiting list and one randomised controlled trial of cognitive behavioural therapy v anxiety management, which showed that cognitive behavioural therapy is more effective in improving severity of body dysmorphic disorder, based on blinded assessments by clinicians.…”

Section: How Is Body Dysmorphic Disorder Managed?mentioning

confidence: 99%